The secondary role of pathology in the present clinical management of pulmonary hypertension (PH) reflects to some extent the limitations of the current understanding of the disease. Ample room exists for the diagnostic translation of the pathobiologic studies, with the goal of improving the diagnostic and prognostic power of the pathologic assessment of pulmonary vascular remodeling. This article seeks to show the complementarities of the pathology and pathobiology of PH.
Pathology of pulmonary hypertension. Publishing Authors By Initials
Pathology of pulmonary hypertension. Journal Published:
PUBLICATION TYPE: Review
Journal: Clinics in chest medicine
VOLUME: 28
Page Numbers: 23-42, vii
Journal Abbreviation: Clin. Chest Med.
ISSN: 0272-5231
DAY: 3
MONTH: Mar
YEAR: 2007
Pathology of pulmonary hypertension. Information
Number of References: 121
LANGUAGE: eng
NlmUniqueID: 7907612
Pathology of pulmonary hypertension. Keywords Mesh Terms:
KEYWORDS: Vascular Resistance
MESH TERMS: physiology
Chemical & Substance for Abstract: Pathology of pulmonary hypertension. Information
Substance Name: Bone Morphogenetic Protein Receptors, Ty
Registry Number: EC 2.7.1.37
Grant and Affiliation Information for Pathology of pulmonary hypertension.
AFFILIATION: Division of Cardiopulmonary Pathology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Research Building, Baltimore, MD 21217, USA. rtuder@jhmi.edu
Country: United States
AGENCY: United States NHLBI
GRANT: R21 HL077805-02
ACRONYM: HL
MEDLINETA: Clin Chest Med
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Pathology of pulmonary hypertension Related Publications